These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20566765)

  • 21. Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice.
    Ji B; Chauffour A; Aubry A; Robert J; Ibrahim M; Jarlier V
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2955-9. PubMed ID: 19364857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance with antimicrobial therapy for buruli ulcer.
    Klis S; Kingma R; Tuah W; Stienstra Y; van der Werf TS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6340. PubMed ID: 25225342
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to "compliance with antimicrobial therapy for buruli ulcer".
    Phillips RO; Sarfo FS; Abass MK; Frimpong M; Ampadu E; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6341. PubMed ID: 25225343
    [No Abstract]   [Full Text] [Related]  

  • 25. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
    Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.
    Webb BJ; Hauck FR; Houp E; Portaels F
    East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
    Cowan R; Athan E; Friedman ND; Hughes AJ; McDonald A; Callan P; Fyfe J; O'Brien DP
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003503. PubMed ID: 25658304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
    Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
    PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
    Schütte D; Umboock A; Pluschke G
    Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
    Schütte D; Um-Boock A; Mensah-Quainoo E; Itin P; Schmid P; Pluschke G
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e2. PubMed ID: 17989779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of avermectins against Mycobacterium ulcerans.
    Omansen TF; Porter JL; Johnson PD; van der Werf TS; Stienstra Y; Stinear TP
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003549. PubMed ID: 25742173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire.
    Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B
    J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074
    [No Abstract]   [Full Text] [Related]  

  • 36. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Walton A; Athan E
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006357. PubMed ID: 29554101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined local and vaginal therapy in Buruli ulcer].
    Milánkovits M
    Orv Hetil; 2010 Aug; 151(35):1434-5. PubMed ID: 20824910
    [No Abstract]   [Full Text] [Related]  

  • 38. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
    Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
    J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Papua New Guinean with three foot ulcers].
    Coenders A; Verregghen M; Baerends EP
    Ned Tijdschr Geneeskd; 2018; 162():D2295. PubMed ID: 29372678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
    Chauty A; Ardant MF; Marsollier L; Pluschke G; Landier J; Adeye A; Goundoté A; Cottin J; Ladikpo T; Ruf T; Ji B
    Clin Infect Dis; 2011 Jan; 52(1):94-6. PubMed ID: 21148526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.